Patients with T2D and overweight/obesity starting GLP-1 therapy may experience a small but statistically significant increase in the risk for depression compared with those starting SGLT2 inhibitors.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/initiating-glp-1-drugs-may-slightly-raise-depression-risk-2025a1000r4t?src=rss
Author :
Publish date : 2025-10-08 13:02:00
Copyright for syndicated content belongs to the linked Source.